Cancer gene therapy using survivin mutant adenovirus

Journal of Clinical Investigation

Volumn 108, Issue 7, 2001, Pages 981-990

  Mesri, Mehdi ^a   Wall, Nathan R ^a   Li, Jia ^a   Kim, Richard W ^a   Altieri, Dario C ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; DNA; GREEN FLUORESCENT PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; KANAMYCIN; SURVIVIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER MODEL; CANCER THERAPY; CELL DEATH; CONTROLLED STUDY; ESCHERICHIA COLI; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTANT; XENOGRAFT;

ADENOVIRUSES, HUMAN; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CHROMOSOMAL PROTEINS, NON-HISTONE; CYSTEINE PROTEINASE INHIBITORS; DOXORUBICIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; MICE; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0034789355     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200112983     Document Type: Article

References (42)

1. The hallmarks of cancer
2. The biochemistry of apoptosis
3. Dysregulation of apoptosis in cancer
4. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
5. Mitochondrial control of cell death
6. IAP family proteins-suppressors of apoptosis
7. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
8. Control of apoptosis and mitotic spindle checkpoint by survivin
9. BIRinging chromosomes through cell division: And survivin' the experience
10. Analysis of human transcriptomes
11. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers
12. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer
13. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas
14. Prognostic significance of survivin expression in diffuse large B-cell lymphomas
15. Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy
16. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
17. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth
18. Inhibition of melanoma tumor growth in vivo by survivin targeting
19. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
20. From bench to clinic with apoptosis-based therapeutic agents
21. cdc2 phosphorylation of survivin
22. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
23. A simplified system for generating recombinant adenoviruses
24. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
25. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
26. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer
27. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer
28. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis
29. Tumor specific gene expression in hepatic metastases by a replication-activated adenovirus vector
30. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
31. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
32. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
33. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
34. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection
35. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7
36. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement
37. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors
38. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
39. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
40. Adenovirus-mediated transfer of a wild transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer
41. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
42. Selectivity of replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen